secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEPHROS INC (NEPH)
CIK:        0001196298
Form:       8-K
Filed at:   2022-11-21T23:59:59+00:00
Accession:  0001493152-22-033098
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 2.01, 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nephros closes sale of Pathogen Detection Systems business to BWSI, LLC
-----------------------------------------------------------------------

- Closing occurred Nov 15, 2022; BWSI made nominal cash payment and assumed certain liabilities.
- Annual royalty of a specified % of gross margin from PDS products for 7 years starting 2023.
- Pro forma for 9M 2022: net loss attributable to Nephros improved from $6.464M to $3.764M.
- Pro forma for FY 2021: net loss attributable to Nephros improved from $4.107M to $3.024M.
- PDS Business classified as discontinued operations; assets/liabilities removed from balance sheet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1196298/000149315222033098/0001493152-22-033098-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1196298/000149315222033098/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-033098

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer